Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: HER2+ Breast Cancer
Interventions: DRUG: Trastuzumab
Sponsor: Rawalpindi Medical College